Organophosphorus insecticides and nerve agents irreversibly inhibit serine hydrolase superfamily enzymes. One enzyme of this superfamily, the industrially important (for β-lactam antibiotic synthesis) AXE/CAH (acetyl xylan esterase/cephalosporin acetyl hydrolase) from the biotechnologically valuable organism Bacillus pumilus, exhibits low sensitivity to the organophosphate paraoxon (diethyl-p-nitrophenyl phosphate, also called paraoxonethyl), reflected in a high K i for it (∼5 mM) and in a slow formation (t 1 2 ∼1 min) of the covalent adduct of the enzyme and for DEP (E-DEP, enzyme-diethyl phosphate, i.e. enzyme-paraoxon). The crystal structure of the E-DEP complex determined at 2.7 Å resolution (1 Å = 0.1 nm) reveals strain in the active Ser 181 -bound organophosphate as a likely cause for the limited paraoxon sensitivity. The strain results from active-sitesize limitation imposed by bulky conserved aromatic residues that may exclude as substrates esters having acyl groups larger than acetate. Interestingly, in the doughnut-like homohexamer of the enzyme, the six active sites are confined within a central chamber formed between two 60
INTRODUCTION
OPs (organophosphorus compounds) have been used extensively for decades to control agricultural and household pests, and have become an important environmental threat [1, 2] , with the compound paraoxon (diethyl-p-nitrophenyl phosphate, also called paraoxon-ethyl), the toxic metabolite of the insecticide parathion, being a paradigmatic representative of these compounds [3] . OPs are highly toxic to mammals including humans [1, 4] and, indeed, have been used as nerve gases [5] . Their toxicity derives mainly from their ability to irreversibly inactivate the enzyme acetylcholinesterase, which plays a key role in terminating neurotransmission at neuromuscular junctions and in the cholinergic synapses of the nervous system [6] . This inactivation results from the selective formation of a stable covalent adduct between the OP and the highly nucleophilic active-centre serine residue belonging to the Glu/His/Ser catalytic triad of acetylcholinesterases [7] . Since the same mechanism is shared by many other enzymes belonging to the α/β-hydrolase superfamily [8] , which use an active-centre highly nucleophilic serine residue as the key catalyst, all of these enzymes should be expected, in principle, to be susceptible to irreversible inhibition by paraoxon and other OPs.
In the present study, we confirm this susceptibility for a representative of an enzyme group belonging to this superfamily and having important biotechnological potential, the AXEs/CAHs (acetyl xylan esterases/cephalosporin C deacetylases), which form group 7 among the carbohydrate esterases in the CAZy (http://www.cazy.org) classification of carbohydrate-active enzymes [9] . These enzymes appear to be homohexameric (see [10] and the discussion therein) and they present unique double specificity, since they catalyse the deacetylation of short acetylated xylo-oligosaccharides ( Figure 1A) , participating in the degradation of the xylan plant-cell-wall component, but they are also cephalosporin C deacetylases ( Figure 1B ), removing the acetyl group at the 3-position of cephalosporin C and of 7-amino cephalosporanic acid ( Figure 1C ) [10] [11] [12] . This latter activity endows AXE/CAHs with industrial interest in the semisynthetic production of β-lactam antibiotics [11] .
In our present study, we have utilized the AXE/CAH from Bacillus pumilus (BpAXE), an industrially highly value organism used for the production of alkaline proteases [13] , for the environmental decontamination of dioxins [14] , in the baking industry [15] , and as a pesticide because strain GB 34 (also called strain 006493) protects soya bean roots against certain fungi (http://www.epa.gov/oppbppd1/biopesticides/ingredients/ factsheets/factsheet_006493.htm). In the present study, we prove that BpAXE is completely inhibited by paraoxon, but we also find by analysing the paraoxon inhibition kinetics [16] that this enzyme has a high K i for this OP and that the collapse of the
Figure 1 Deacetylation reactions catalysed by AXEs/CAHs
Substrates used include short xylo-oligosaccharides (A), cephalosporin C (B) and 7-amino cephalosporanic acid (C). p-NPA is also deacylated (D) and was used in the present study to monitor the reaction.
non-covalent complex with the inhibitor to the irreversible adduct is slow. These findings indicate that the paraoxon sensitivity of this enzyme is low compared with those of acetylcholinesterases [17] and carboxylesterases [18] , the classical enzymes on which the effects of paraoxon were characterized.
Previously, one enzyme of the serine hydrolase superfamily, the D-type esterase S-formylglutathione hydrolase, was proven to be paraoxon-insensitive because of the presence of a tryptophan residue blocking access of paraoxon to the catalytic serine [19] . However, the alignment with D-type esterases failed to reveal such a tryptophan residue in AXE/CAHs (results not shown). To try to understand the reduced sensitivity of BpAXE to paraoxon we have determined the crystal structure at 2.7 Å resolution (1 Å = 0.1 nm) of BpAXE in the presence of this OP. This structure, together with that of paraoxon-free BpAXE at 1.9 Å resolution, are reported in the present paper, revealing a doughnut-like homohexameric 32-point-group architecture formed by two 60
• -staggered trimers in which the subunits present a modification of the classical α/β-hydrolase fold [8] . The structure obtained in the presence of paraoxon allows rationalization of the decreased paraoxon sensitivity of BpAXE, since although each enzyme subunit is found to host one DEP (diethyl phosphate) molecule covalently bound to the active-site serine residue, there is evidence of steric hindrance to accommodating the DEP. The conservation of the residues causing this steric hindrance indicates that AXEs/CAHs from other organisms should exhibit similarly low paraoxon sensitivity. The comparison of the structures of the ligandfree and DEP-containing structures reveals a lack of significant conformational changes upon paraoxon binding and catalysis, indicating that AXEs/CAHs are highly rigid catalysts that might offer a favourable case for trying to devise industrially interesting artificial chemical catalysts resembling these enzymes.
EXPERIMENTAL Enzyme purification
PCR amplification of the AXE gene from genomic DNA of B. pumilus strain CECT5072 using primers derived from the B. pumilus PS213 AXE gene sequence (GenBank ® accession number AJ249957) [20] , its cloning into pET28a (Novagene) and the production of the protein (containing a 36-residue N-terminal extension hosting a His 6 tag) from this plasmid in Escherichia coli Rosetta (DE3) pLys cells have been reported previously [12] . For large-scale enzyme production, the cells were grown with aeration at 37
• C, to a D 600 of 1. 8 .0, were broken in a mill homogenizer (Mini Zeta IIE, Netzsch), the homogenate was centrifuged again, the supernatant was incubated for 30 min with 3 units · ml − 1 DNAase I (Sigma) and was centrifuged once more before 5-fold concentration by ultrafiltration through a 100 kDa cut-off membrane (QuixStand System, GE Healthcare), prior to application to three 5 ml HiTrapCaptoQ columns placed in series in anÄKTAprime TM Plus purifier (GE Healthcare) which had been equilibrated with 0.05 M Tris/HCl, pH 8.0. After washing with a 100 ml linear gradient of 0-0.25 M NaCl, the enzyme was eluted isocratically with 300 ml of the 0.25 M NaCl solution in the same buffer. Pooled enzyme-containing fractions were applied to a 5 ml HisTrap FF column (GE Healthcare) equilibrated and washed with 0.05 M Tris/HCl, pH 8.0, 5 mM imidazole and 0.5 M NaCl, eluting the enzyme with a 200 ml linear imidazole gradient (0-0.5 M imidazole). Pure AXE (monitored by SDS/PAGE) was eluted at 0.04-0.06 M imidazole. AXE was freed from imidazole using HiTrap desalting columns (GE Healthcare), concentrated to 5-10 mg · ml − 1 by centrifugal ultrafiltration (100 kDa filter devices from Amicon) and stored at − 80
• C. 7 .0, and p-NPA at a concentration of either 2 mM (standard assay) or in the 0-15 mM range (when determining K m and V max values). Non-enzymatic p-NPA hydrolysis was negligible. The dependency of the velocity on the concentration of p-NPA was hyperbolic. Inhibition by organophosphates was analysed by continuously following p-NPA hydrolysis after adding the enzyme to the assay solution containing 2 mM p-NPA and one of the following: 20 mM DFP (di-isopropylfluorophosphate), 0-20 mM paraoxon-methyl (dimethyl-p-nitrophenyl phosphate) or 0-8 mM paraoxon (upper concentration limits set by solubility). The amount of enzyme added in these assays was proportional to that of paraoxon (0.028 μg · ml − 1 per mM paraoxon). Eqns (1)- (3) apply to a competitive irreversible inhibitor ( Figure 2A ) [21] [22] [23] [24] and were used to analyse organophosphate inhibition from reaction-progress curves:
too small and thus the enzyme was detected by enzyme-activity assays in fractions collected from the column. The results are shown in arbitrary units to fit all of them on a single graph. [
where [16] . Plots of λ (determined from progress curves using eqn 2) against the concentration of organophosphate were hyperbolic as demanded by eqn (3) and allowed determination of k i (the value of λ at [paraoxon] = ∞) and K i (app), since [S] was 2 mM and the K m (for p-NPA) was determined independently from substrate-velocity studies. Curve fitting was carried out with GraphPad Prism (GraphPad Software).
Crystallization and data collection
The sparse matrix vapour-diffusion sampling procedure [25] was used for screening crystallization conditions at 21 Crystals frozen directly from the drop were diffracted at 100 K (Oxford Cryosystems) at the ESRF (European Synchrotron Radiation Facility) synchrotron (Grenoble), using beamline ID23-1 and an ADSC Quantum 315r CCD (charge-coupled device) detector (BpAXE-apo), or beamline BM16 and an ADSC Quantum 210r CCD detector (BpAXE-DEP), yielding respective datasets at 1.9 and 2.7 Å resolution. Data processed with MOSFLM, SCALA and TRUNCATE [26] (Table 1) revealed monoclinic cells (space group P2 1 ) of different dimensions (Table 1) which contained in the asymmetric unit (see below) two and one enzyme homohexamers respectively with 48 % and 45 % solvent contents.
Structure solution and refinement
Phases were determined by molecular replacement with MOLREP [27] using as a search model for BpAXE-apo one subunit of BsAXE (AXE/CAH from Bacillus subtilis) (PDB code 1ODS) devoid of ligands and water molecules. The structure obtained in this way (see below) of the BpAXE-apo hexamer was used for molecular replacement in the BpAXE-DEP crystal. The solutions consisted of 12 chains forming two hexamers (BpAXE-apo) or six chains forming one hexamer (BpAXE-DEP) in the asymmetric unit. Rigid-body refinement was performed stepwise with increased resolution, and it was followed by automated refinement using the program REFMAC 5 [26] alternating with graphic manual model adjustment sessions with the program COOT [28] . Initial phases were improved by density modification using histogram matching, solvent flattening and density averaging as implemented in the program DM [26] . Electron density from the resulting difference maps was interpreted, and a model of the protein was constructed except for the three C-terminal residues in both structures and for residues 1-7 of the BpAXE-DEP. B factors and positional non-crystallographic symmetry restraints were used and gradually released as refinement progressed. All of the diffraction data were used throughout the refinement process except for the 5 % randomly selected data for calculating R free . Crystal twinning was detected in the BpAXE-apo crystal (twin fraction 0.46), being refined as the BpAXE-DEP but including the twinning correction option available in REFMAC5 (v5.5.088). TLS (translation/libration/screw) was applied in the last steps of refinement with the TLSMD server for definition of the TLS groups [29] . The final models at 1.9 Å (BpAXE-apo) or 2.7 Å (BpAXE-DEP) resolution exhibited excellent R factor /R free values (Table 1) , and included two hexamers (residues 1-317 in each subunit) (BpAXE-apo) or one hexamer (residues 7-317) (BpAXE-DEP) in the asymmetric unit. In the case of the BpAXE-DEP crystal, non-protein electron density was found in the active centre of each subunit, which best fitted bound DEP. Structure analysis with PROCHECK yielded excellent stereochemistry for both models (Table 1) [30] .
Superposition of structures and rmsd (root mean square deviation) calculations were carried out with the SSM option of the program COOT [28] using default parameters. Figures were drawn using PyMOL (http://www.pymol.org).
Other methods
Protein concentration was determined by the method of Bradford [32] using BSA as the standard. SDS/PAGE was performed using 12 % polyacrylamide gels, followed by Coomassie Blue staining. Analytical gel-filtration chromatography was carried out as reported previously [33] , using a Superdex 200 (10/300) column mounted on anÄKTA FPLC system (GE Healthcare Life Sciences). The column was equilibrated and run at 24
• C with a solution of 0.05 M Tris/HCl, pH 7.5, and 0.15 M NaCl. A semi-logarithmic plot of the molecular masses of marker proteins (Sigma) against the distribution coefficient (K d ) for each protein was used for estimating the mass of BpAXE. K d values were calculated from the expression
, where V o , V i , and V e are the elution volumes of Dextran Blue, water (estimated by monitoring conductivity) and the protein of interest respectively.
RESULTS AND DISCUSSION

Characteristics of BpAXE and irreversible inhibition by paraoxon
Sequence comparisons [10] , molecular-mass estimates (Figure 2B ) and enzyme-activity assays [12] prove that BpAXE is a typical AXE/CAH. The gene for this enzyme (see the Experimental section) encodes a polypeptide chain having essentially the same length (320 residues) as, and 41 %, 76 % and 89 % sequence identity with, the AXEs/CAHs from Thermotoga maritima, B. subtilis and B. pumilus strain P213 respectively [10] . As expected from members of CE-7 (carbohydrate esterase family, group 7), all of these enzymes present the CE-7 'signature' [10] which consists of three strictly conserved sequence motifs: RGQ, GxSQG (which hosts the catalytic serine residue) and HE (which hosts the histidine residue of the catalytic triad). Concerning oligomeric structure, BpAXE is hexameric, both in solution, as indicated by size-exclusion chromatography results ( Figure 2B ) obtained over a very large range of enzyme concentrations (1.8 nM to 36 μM) (smaller panel in Figure 2B ), and in crystalline form (see below). This is characteristic of AXEs/CAHs, as proven structurally also for BsAXE [10] . Finally, the enzyme from B. pumillus catalysed the deacetylation of acetylxylan, 7-amino-3-deacetylcephalosporanic acid and cephalosporin C ( Figures 1B and 1C ) [12] . Its high activity with the artificial substrate p-NPA (K m and V max values, determined in the present study at 25
• C, are 1.6 + − 0.5 mM and 16.5 + − 0.2 units · mg − 1 respectively), which is also a characteristic of AXEs ( Figure 1D ) as described for BsAXE [10] , has been exploited in the present study for assaying enzyme activity by continuously following the production of the coloured product, p-nitrophenol.
Addition of BpAXE to a solution containing both p-NPA and paraoxon resulted in fast initial production of p-NPA (monitored by the rapid colour increase) which progressively decreased with time until it stopped completely ( Figure 2C ). The final amount of colour obtained ( Figure 2C) indicates that, at the 1.18×10 − 7 enzyme hexamer/paraoxon molar ratio used, only 8 % of the p-NPA was hydrolysed, excluding that substrate depletion accounted for the observed decrease with time in the reaction rate. The presence of abundant substrate after the reaction had stopped was confirmed by adding a second enzyme sample: the reaction restarted again and gradually declined again until it was stopped, as with the first addition (results not shown). This gradually decreasing rate of product release is typical of irreversible inhibitors [21] , reflecting the time taken for reaction of the enzyme molecules with the inhibitor [22] .
BpAXE exhibits low sensitivity to paraoxon
Figure 2(C) demonstrates for BpAXE that product accumulation in the presence of paraoxon increases according to an exponential having the form of eqn (2) (see the Experimental section). Under the conditions used of constant substrate concentration and [E]/[I] ratio, the amount of product accumulated (P ∞ ) when the inhibition was complete was the same for the different paraoxon concentrations used. This is the expected behaviour (see eqn 1) for an irreversible inhibitor that competes with the substrate [16] . Also, as expected for this type of inhibition (eqns 1 and 3), the time to reach complete inhibition decreased as the concentrations of inhibitor and enzyme were increased ( Figure 2C) , and the value of the first-order rate constant for product accumulation (λ in eqn 1) depended hyperbolically on the concentration of paraoxon ( Figure 2C, inset) . The latter plot allowed the estimation of values for K i (app) and k i for paraoxon of ∼5.4 mM and 0.012 s respectively (for 2 mM p-NPA in the assay and a K m for p-NPA of 1.64 mM). These K i (app) and k i values are ∼30-fold higher and lower respectively than those reported for the acetylcholinesterase from electric eel [17] , and they are also much poorer than those reported for the carboxylesterase EST2 from Alicyclobacillus acidocaldarius [18] , indicating that BpAXE is much less sensitive to paraoxon than are these other enzymes.
Structure of BpAXE
To investigate the reasons for the low paraoxon sensitivity of BpAXE and to determine whether the bound inhibitor triggers conformational changes, BpAXE crystals were prepared in the absence of ligands (BpAXE-apo) or in the presence of paraoxon (BpAXE-DEP). The structures of these crystalline enzyme forms were determined (see the Experimental section) at respective resolutions of 1.9 Å and 2.7 Å, with excellent quality control indicators (Table 1) . They corresponded to doughnut-like homohexamers that can be described as a dimer of two trimers having their three-fold axes aligned, but which are staggered by 60
• (Figures 3A and 3B ). Each subunit contacts extensively two subunits of the other trimer, burying surfaces (determined with a probe of 1.4 Å diameter) of 841 Å 2 in one subunit and 1196 Å 2 in the other subunit and also making less extensive contacts (buried surfaces of 449 and 272 Å 2 ) with the other two subunits of the same trimer. Both the apo and the DEP-containing structures replicate closely the reported structure of BsAXE (PDB code 1ODS) (rmsd values of 0.38 and 0.41 Å for superimposition of 317 and 311 Cα atoms respectively). The subunits' fold differs from the canonical α/β-hydrolase fold in the presence of an extra three-helix bundle (between α6 and β8; green in Figure 3C ), as well as the presence of a second insertion consisting of two α-helices and a β-strand at the N-terminus (blue in Figure 3C ) [10] . The three-helix bundle insertion may play a key role in hexamer formation, since it interacts with one subunit of the adjacent trimer and with another from the same trimer ( Figure 3B , helices shown in ribbon representation), in this latter case contacting the loop preceding the C-terminal α-helix (α11), which hosts the crucial His 298 of the catalytic triad. This interaction, and thus trimer formation, may be important for stabilizing the active centre and the nearby substrate gorge [10] , which involves the loop preceding α11 and the beginning of this helix. The hexameric nature of this enzyme may be related to the need to limit the substrate size [10] , since the six active centre are confined within a central chamber ( Figure 3D ) which can be accessed through a central opening ( Figure 3B ). In agreement with the strong The structure of the covalent adduct with DEP explains the low sensitivity to this organophosphate and provides clues on how these enzymes select for the size of the acyl substituent to be removed Electron-density maps ( Figure 4B ) of the crystal grown in the presence of paraoxon revealed a large mass of density that is continuous with that of the Ser 181 Oγ and which fits a DEP group, the moiety of paraoxon that would be expected to bind covalently to the catalytic serine residue following the oxyanion attack by the catalytic serine residue with release of the p-nitrophenyl moiety. The position of the DEP is similar, but not identical, to that of the DEP found in the active centre of the plant carboxylesterase AeCXE1 (carboxylesterase 1 from Actinida eriantha) [34] (Figure 4C) • observed for the P-O-C Ser angle at the Ser-phosphate bridge ( Figure 4B ), instead of an ideal angle near 110
• . This steric hindering and somewhat strained geometry could hamper the binding and may make the reaction of paraoxon with the oxyanion in Ser 181 difficult, explaining the high K i (app) and low k i of BpAXE for paraoxon. This interpretation is supported by the observations that the smaller organophosphate paraoxon-methyl inactivates the enzyme with much more favourable constants than paraoxon-ethyl [K i (app) of 13.4 μM and ∼5.4 mM respectively, and respective k i values of 0.279 and 0.012 s − 1 ; Figure 2D and its inset], whereas the larger organophosphate DFP fails to inactivate BpAXE, even at a concentration of 20 mM ( Figure 2D ).
Given the conservation of Tyr 91 , Tyr 206 and of the hydrophobic cushion on which Tyr 206 sits in all AXEs/CAHs [10] , and also given the very good superimposition (results not shown) of the structures of the active centres of BpAXE, BsAXE, and of the deposited (but not published) structure of the AXE/CAH from Thermotoga maritima (PDB code 3M81), it is clear that the structurally hampered fitting and strained adduct conformation should be constant features of paraoxon binding to all AXEs/CAHs, predicting poor sensitivity to this organophosphate for all of these enzymes. In contrast, as already indicated, no such structural hampering and conformational strain are observed with the DEP adduct observed in the structure of AeCXE1 [34] , a carboxylesterase in which Tyr 91 and Tyr 206 are replaced by glycine residues and where there is no obvious hydrophobic cushion blocking this part of the active centre ( Figure 4C ). In the superimposition of the active centre of this enzyme with BpAXE ( Figure 4C ), the bound DEP has moved an average value of 1.4 Å away from the main chain of Gly 92 (corresponding to Tyr 91 of BpAXE), invading the position that would be occupied in BpAXE by the phenolic ring of Tyr 206 , but which is accessible in AeCXE1 because of the lack of a side chain in Gly 92 , thus permitting unstrained DEP binding with optimal geometry (Figure 4C) . Correspondingly, the sensitivity of this enzyme to paraoxon should be higher than in the case of BpAXE, in line with the observations with the carboxylesterase EST2 [18] .
The strained DEP binding to BpAXE reflects the fact that the active centre of BpAXE, and in general of AXEs/CAHs, appears to have evolved for selecting against substrates carrying acyl groups larger than the acetyl substituent [10, 35, 36] . The presence in BpAXE of Tyr 206 and of the hydrophobic cushion blocks the active site around Ser 181 , leaving enough space for accommodating an acetyl group, but preventing the accommodation of larger substituents such as a butyryl group. Correspondingly, the binding of the larger phosphate group in paraoxon should also be hampered ( Figure 5B ). In fact, no activity was detected with BpAXE towards 2 mM p-nitrophenyl butyrate, in line with the preference of AXEs for acetylated substrates [10, [35] [36] [37] . The importance of the steric obliteration of the site for conferring acyl group specificity is highlighted by the comparison with AeCXE1, which uses substrates with a butyryl group substituent most efficiently [34] and which has no Tyr 206 or hydrophobic cushion blocking the active site, which thus is large enough to accommodate a butyryl substituent ( Figure 5C ). Another example illustrating the importance of active-site steric restriction for conferring specificity for the acyl group to be removed is provided by S-formylglutathione hydrolase, an esterase which removes the very small formyl group from its substrate [19, 38] . In this case, the blocking of the active centre is more drastic than for AXEs/CAHs, since a bulky tryptophan residue sitting next to the active-centre serine residue allows reaction with a formyl group, but precludes access of larger substituents, thus rendering the enzyme totally insensitive to organophosphates because of the large size of the phosphate ( Figure 5A ) [19, 38] . 
BpAXE appears to be a mechanically rigid catalytic device
The BpAXE-apo and BpAXE-DEP structures are virtually identical, as revealed by their superimposition both at the level of individual units (rmsd of 0.20 Å for 311 Cα atoms) or as complete hexamers (rmsd of 0.35 Å for 1866 Cα atoms) ( Figure 5E ). This similarity extends to the disposition of the active-centre residues, except for slight movements of <1 Å of amino acid side chains around the tetrahedral covalent intermediate in the BpAXE structure ( Figure 4D) . Clearly, the binding of paraoxon and the generation of the covalent adduct does not induce any conformational change, strongly suggesting that substrate binding and catalysis by BpAXE does not involve important movements on the enzyme. Thus, given our detailed structural and chemical information on these enzymes derived from the present study and from other studies [10] , and since AXEs/CAHs appear to be rigid size-selecting solid catalytic devices resembling in this respect the zeolytic catalysts used in the chemical industry [39] , they may be ideal subjects for trying to recreate them artificially on zeolytic sizing substrates. This possibility would have practical interest derived from the industrial potential of these enzymes for making antibiotics [11] . 
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